Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Litvan

Showing results (171-180 of 331) with videos related to

Pageof 34
Sort By:
Neurology|June 11, 2020
Clinical and pathologic features of cognitive-predominant corticobasal degenerationNobutaka Sakae, Octavio A Santos, Otto Pedraza, et al.
Annals of Neurology|January 27, 2006
Lrrk2 and Lewy body diseaseOwen A Ross, Mathias Toft, Andrew J Whittle, et al.
BMC Medical Genetics|March 20, 2012
Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control studyLisa F Potts, Alex C Cambon, Owen A Ross, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|February 23, 2021
Medication Management Performance in Parkinson's Disease: Examination of Process ErrorsCatherine A Sumida, Francesca V Lopez, Emily J Van Etten, et al.
Parkinsonism & Related Disorders|July 24, 2010
Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's diseaseScott Bickel, Lazaro Alvarez, Raul Macias, et al.
Journal of Alzheimer'S Disease : JAD|November 10, 2018
Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino VolunteersJose A Soria, Branko N Huisa, Steven D Edland, et al.
Movement Disorders Clinical Practice|May 18, 2022
Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease DementiaJudith A Boel, Rob M A de Bie, Ben A Schmand, et al.
Neurology. Clinical Practice|March 3, 2023
Enrollment of Participants From Marginalized Racial and Ethnic Groups: A Comparative Assessment of the STEADY-PD III and SURE-PD3 TrialsDaniel G Di Luca, Eric A Macklin, Karen Hodgeman, et al.
Parkinsonism & Related Disorders|September 28, 2020
Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal studyKelly A Mills, Ruth B Schneider, Marie Saint-Hilaire, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 30, 2010
A recommended scale for cognitive screening in clinical trials of Parkinson's diseaseKelvin L Chou, Melissa M Amick, Jason Brandt, et al.
Pageof 34

Showing results (171-180 of 331) with videos related to

Sort By:
Pageof 34
Neurology|June 11, 2020
Clinical and pathologic features of cognitive-predominant corticobasal degenerationNobutaka Sakae, Octavio A Santos, Otto Pedraza, et al.
Annals of Neurology|January 27, 2006
Lrrk2 and Lewy body diseaseOwen A Ross, Mathias Toft, Andrew J Whittle, et al.
BMC Medical Genetics|March 20, 2012
Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control studyLisa F Potts, Alex C Cambon, Owen A Ross, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|February 23, 2021
Medication Management Performance in Parkinson's Disease: Examination of Process ErrorsCatherine A Sumida, Francesca V Lopez, Emily J Van Etten, et al.
Parkinsonism & Related Disorders|July 24, 2010
Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's diseaseScott Bickel, Lazaro Alvarez, Raul Macias, et al.
Journal of Alzheimer'S Disease : JAD|November 10, 2018
Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino VolunteersJose A Soria, Branko N Huisa, Steven D Edland, et al.
Movement Disorders Clinical Practice|May 18, 2022
Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease DementiaJudith A Boel, Rob M A de Bie, Ben A Schmand, et al.
Neurology. Clinical Practice|March 3, 2023
Enrollment of Participants From Marginalized Racial and Ethnic Groups: A Comparative Assessment of the STEADY-PD III and SURE-PD3 TrialsDaniel G Di Luca, Eric A Macklin, Karen Hodgeman, et al.
Parkinsonism & Related Disorders|September 28, 2020
Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal studyKelly A Mills, Ruth B Schneider, Marie Saint-Hilaire, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 30, 2010
A recommended scale for cognitive screening in clinical trials of Parkinson's diseaseKelvin L Chou, Melissa M Amick, Jason Brandt, et al.
Pageof 34